{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T22:25:39Z","timestamp":1792016739851,"version":"4.4.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T00:00:00Z","timestamp":1721692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.brainres.2024.149132","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T13:00:06Z","timestamp":1721739606000},"page":"149132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer\u2019s disease"],"prefix":"10.1016","volume":"1843","author":[{"given":"Tara","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaeli J.","family":"Knudsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawn A.","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2024.149132_b0005","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.tcb.2011.06.004","article-title":"Central nervous system myelin: structure, synthesis and assembly","volume":"21","author":"Aggarwal","year":"2011","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.brainres.2024.149132_b0010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.nlm.2010.10.008","article-title":"Ciproxifan, an H3 receptor antagonist, alleviates hyperactivity and cognitive deficits in the APP Tg2576 mouse model of Alzheimer's disease","volume":"95","author":"Bardgett","year":"2011","journal-title":"Neurobiol Learn Mem."},{"key":"10.1016\/j.brainres.2024.149132_b0015","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.1093\/hmg\/ddv305","article-title":"A novel type of rhizomelic chondrodysplasia punctata, RCDP5, is caused by loss of the PEX5 long isoform","volume":"24","author":"Baroy","year":"2015","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0020","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","article-title":"Functions of plasmalogen lipids in health and disease","volume":"1822","author":"Braverman","year":"2012","journal-title":"Biochim Biophys Acta."},{"key":"10.1016\/j.brainres.2024.149132_b0025","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/ng0497-369","article-title":"Human PEX7 encodes the peroxisomal PTS2 receptor and is responsible for rhizomelic chondrodysplasia punctata","volume":"15","author":"Braverman","year":"1997","journal-title":"Nat Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0030","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.ymgme.2009.12.005","article-title":"A Pex7 hypomorphic mouse model for plasmalogen deficiency affecting the lens and skeleton","volume":"99","author":"Braverman","year":"2010","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.brainres.2024.149132_b0035","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1093\/hmg\/ddg236","article-title":"Impaired neuronal migration and endochondral ossification in Pex7 knockout mice: a model for rhizomelic chondrodysplasia punctata","volume":"12","author":"Brites","year":"2003","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0040","doi-asserted-by":"crossref","first-page":"e28539","DOI":"10.1371\/journal.pone.0028539","article-title":"Alkyl-glycerol rescues plasmalogen levels and pathology of ether-phospholipid deficient mice","volume":"6","author":"Brites","year":"2011","journal-title":"PLoS One."},{"key":"10.1016\/j.brainres.2024.149132_b0045","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/hmg\/dds097","article-title":"Impaired neurotransmission in ether lipid-deficient nerve terminals","volume":"21","author":"Brodde","year":"2012","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0050","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.ajhg.2014.10.003","article-title":"A peroxisomal disorder of severe intellectual disability, epilepsy, and cataracts due to fatty acyl-CoA reductase 1 deficiency","volume":"95","author":"Buchert","year":"2014","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0055","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1172\/JCI72063","article-title":"Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination","volume":"124","author":"da Silva","year":"2014","journal-title":"J Clin Invest."},{"key":"10.1016\/j.brainres.2024.149132_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-3639.2011.00504.x","article-title":"Neuroanatomical, sensorimotor and cognitive deficits in adult rats with white matter injury following prenatal ischemia","volume":"22","author":"Delcour","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.brainres.2024.149132_b0065","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s11571-022-09859-2","article-title":"Primate brain pattern-based automated Alzheimer's disease detection model using EEG signals","volume":"17","author":"Dogan","year":"2023","journal-title":"Cognitive Neurodynamics."},{"key":"10.1016\/j.brainres.2024.149132_b0070","article-title":"Lattice 123 pattern for automated Alzheimer\u2019s detection using EEG signal","author":"Dogan","year":"2024","journal-title":"Cognitive"},{"key":"10.1016\/j.brainres.2024.149132_b0075","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1111\/jnc.14082","article-title":"Reduced muscle strength in ether lipid-deficient mice is accompanied by altered development and function of the neuromuscular junction","volume":"143","author":"Dorninger","year":"2017","journal-title":"J Neurochem."},{"key":"10.1016\/j.brainres.2024.149132_b0080","doi-asserted-by":"crossref","DOI":"10.1093\/hmg\/ddz040","article-title":"Disturbed Neurotransmitter Homeostasis in Ether Lipid Deficiency","author":"Dorninger","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.brainres.2024.149132_b0085","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1515\/CCLM.2009.205","article-title":"Plasmalogens as a marker of elevated systemic oxidative stress in Parkinson's disease","volume":"47","author":"Dragonas","year":"2009","journal-title":"Clin Chem Lab Med."},{"key":"10.1016\/j.brainres.2024.149132_b0090","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ajmg.a.37404","article-title":"Congenital heart defects common in rhizomelic chondrodysplasia punctata","volume":"170A","author":"Duker","year":"2016","journal-title":"Am J Med Genet a."},{"key":"10.1016\/j.brainres.2024.149132_b0095","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1002\/ajmg.a.37961","article-title":"Growth charts for individuals with rhizomelic chondrodysplasia punctata","volume":"173","author":"Duker","year":"2017","journal-title":"Am J Med Genet a."},{"key":"10.1016\/j.brainres.2024.149132_b0100","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/ajmg.a.61413","article-title":"Rhizomelic chondrodysplasia punctata morbidity and mortality, an update","volume":"182","author":"Duker","year":"2020","journal-title":"Am J Med Genet a."},{"key":"10.1016\/j.brainres.2024.149132_b0105","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2119\/molmed.2011.00119","article-title":"Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease","volume":"17","author":"Fabelo","year":"2011","journal-title":"Mol Med."},{"key":"10.1016\/j.brainres.2024.149132_b0110","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/brb3.41","article-title":"Thy1-hAPP(Lond\/Swe+) mouse model of Alzheimer's disease displays broad behavioral deficits in sensorimotor, cognitive and social function","volume":"2","author":"Faizi","year":"2012","journal-title":"Brain Behav."},{"key":"10.1016\/j.brainres.2024.149132_b0115","article-title":"Oral administration of a synthetic vinyl-ether plasmalogen normalizes open field activity in a mouse model of Rhizomelic chondrodysplasia punctata","author":"Fallatah","year":"2019","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.brainres.2024.149132_b0120","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1177\/107385840100700308","article-title":"Plasmalogens: workhorse lipids of membranes in normal and injured neurons and glia","volume":"7","author":"Farooqui","year":"2001","journal-title":"Neuroscientist."},{"key":"10.1016\/j.brainres.2024.149132_b0125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0006-8993(95)00931-F","article-title":"Disease and anatomic specificity of ethanolamine plasmalogen deficiency in Alzheimer's disease brain","volume":"698","author":"Ginsberg","year":"1995","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2024.149132_b0130","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1021\/bi00185a019","article-title":"Plasmenylethanolamine facilitates rapid membrane fusion: a stopped-flow kinetic investigation correlating the propensity of a major plasma membrane constituent to adopt an HII phase with its ability to promote membrane fusion","volume":"33","author":"Glaser","year":"1994","journal-title":"Biochemistry."},{"key":"10.1016\/j.brainres.2024.149132_b0135","doi-asserted-by":"crossref","first-page":"12193","DOI":"10.1021\/bi00038a013","article-title":"Rapid plasmenylethanolamine-selective fusion of membrane bilayers catalyzed by an isoform of glyceraldehyde-3-phosphate dehydrogenase: discrimination between glycolytic and fusogenic roles of individual isoforms","volume":"34","author":"Glaser","year":"1995","journal-title":"Biochemistry."},{"key":"10.1016\/j.brainres.2024.149132_b0140","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1194\/jlr.P700023-JLR200","article-title":"Peripheral ethanolamine plasmalogen deficiency: a logical causative factor in Alzheimer's disease and dementia","volume":"48","author":"Goodenowe","year":"2007","journal-title":"J Lipid Res."},{"key":"10.1016\/j.brainres.2024.149132_b0145","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/00005072-199907000-00008","article-title":"Decrease and structural modifications of phosphatidylethanolamine plasmalogen in the brain with Alzheimer disease","volume":"58","author":"Guan","year":"1999","journal-title":"J Neuropathol Exp Neurol."},{"key":"10.1016\/j.brainres.2024.149132_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2017.08.026","article-title":"Serum lipid alterations in GBA-associated Parkinson's disease","author":"Guedes","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.brainres.2024.149132_b0155","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/1567205052772786","article-title":"Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: implication of the role of lipids in the pathogenesis of Alzheimer's disease","volume":"2","author":"Han","year":"2005","journal-title":"Curr Alzheimer Res."},{"key":"10.1016\/j.brainres.2024.149132_b0160","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1471-4159.2001.00332.x","article-title":"Plasmalogen deficiency in early Alzheimer's disease subjects and in animal models: molecular characterization using electrospray ionization mass spectrometry","volume":"77","author":"Han","year":"2001","journal-title":"J Neurochem."},{"key":"10.1016\/j.brainres.2024.149132_b0165","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1006\/dbio.2002.0597","article-title":"Efficient recombination in diverse tissues by a tamoxifen-inducible form of Cre: a tool for temporally regulated gene activation\/inactivation in the mouse","volume":"244","author":"Hayashi","year":"2002","journal-title":"Dev Biol."},{"key":"10.1016\/j.brainres.2024.149132_b0170","doi-asserted-by":"crossref","first-page":"5698","DOI":"10.1038\/s41467-020-19473-7","article-title":"Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease","volume":"11","author":"Huynh","year":"2020","journal-title":"Nat Commun."},{"key":"10.1016\/j.brainres.2024.149132_b0175","doi-asserted-by":"crossref","unstructured":"Kaddurah-Daouk, R., McEvoy, J., Baillie, R., Zhu, H., J, K.Y., Nimgaonkar, V.L., Buckley, P.F., Keshavan, M.S., Georgiades, A., Nasrallah, H.A., 2012. Impaired plasmalogens in patients with schizophrenia. Psychiatry Res. 198, 347-52.","DOI":"10.1016\/j.psychres.2012.02.019"},{"key":"10.1016\/j.brainres.2024.149132_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.medengphy.2023.103971","article-title":"ExHiF: Alzheimer's disease detection using exemplar histogram-based features with CT and MR images","volume":"115","author":"Kaplan","year":"2023","journal-title":"Medical Engineering & Physics."},{"key":"10.1016\/j.brainres.2024.149132_b0185","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s11064-006-9061-7","article-title":"Evidence that plasmalogen is protective against oxidative stress in the rat brain","volume":"31","author":"Kuczynski","year":"2006","journal-title":"Neurochem Res."},{"key":"10.1016\/j.brainres.2024.149132_b0190","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2011.02.002","article-title":"Blind sterile 2 (bs2), a hypomorphic mutation in Agps, results in cataracts and male sterility in mice","volume":"103","author":"Liegel","year":"2011","journal-title":"Mol Genet Metab."},{"key":"10.1016\/j.brainres.2024.149132_b0195","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ymgmr.2014.06.003","article-title":"Alkylglycerone phosphate synthase (AGPS) deficient mice: models for rhizomelic chondrodysplasia punctate type 3 (RCDP3) malformation syndrome","volume":"1","author":"Liegel","year":"2014","journal-title":"Mol Genet Metab Rep."},{"key":"10.1016\/j.brainres.2024.149132_b0200","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0005-2736(91)90277-F","article-title":"Stabilization of non-bilayer structures by the etherlipid ethanolamine plasmalogen","volume":"1061","author":"Lohner","year":"1991","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.brainres.2024.149132_b0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s13023-021-01889-z","article-title":"Genetic epidemiology approach to estimating birth incidence and current disease prevalence for rhizomelic chondrodysplasia punctata","volume":"16","author":"Luisman","year":"2021","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.brainres.2024.149132_b0210","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.freeradbiomed.2015.03.012","article-title":"Plasmalogen phospholipids protect internodal myelin from oxidative damage","volume":"84","author":"Luoma","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.brainres.2024.149132_b0215","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neurobiolaging.2016.08.027","article-title":"Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases","volume":"49","author":"Marin","year":"2017","journal-title":"Neurobiol. Aging."},{"key":"10.1016\/j.brainres.2024.149132_b0220","doi-asserted-by":"crossref","first-page":"e0151020","DOI":"10.1371\/journal.pone.0151020","article-title":"Plasmalogen Augmentation Reverses Striatal Dopamine Loss in MPTP Mice","volume":"11","author":"Miville-Godbout","year":"2016","journal-title":"PLoS One."},{"key":"10.1016\/j.brainres.2024.149132_b0225","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.bcmd.2014.01.005","article-title":"Gaucher disease: plasmalogen levels in relation to primary lipid abnormalities and oxidative stress","volume":"53","author":"Moraitou","year":"2014","journal-title":"Blood Cells Mol Dis."},{"key":"10.1016\/j.brainres.2024.149132_b0230","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/ng0497-377","article-title":"Rhizomelic chondrodysplasia punctata is a peroxisomal protein targeting disease caused by a non-functional PTS2 receptor","volume":"15","author":"Motley","year":"1997","journal-title":"Nat Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0235","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0006-8993(00)02205-8","article-title":"Phospholipid composition and levels are altered in Down syndrome brain","volume":"867","author":"Murphy","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2024.149132_b0240","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0163-7827(01)00003-0","article-title":"Plasmalogens: biosynthesis and functions","volume":"40","author":"Nagan","year":"2001","journal-title":"Prog Lipid Res."},{"key":"10.1016\/j.brainres.2024.149132_b0245","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/825157","article-title":"Limited effects of an eIF2\u03b1S51A allele on neurological impairments in the 5xFAD mouse model of Alzheimer's disease","volume":"2015","author":"Paesler","year":"2015","journal-title":"Neural Plast."},{"key":"10.1016\/j.brainres.2024.149132_b0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1517\/17460441.2015.1041913","article-title":"Rodent models for Alzheimer's disease drug discovery","volume":"10","author":"Puzzo","year":"2015","journal-title":"Expert Opin Drug Discov."},{"key":"10.1016\/j.brainres.2024.149132_b0255","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/hmg\/ddg191","article-title":"Inactivation of ether lipid biosynthesis causes male infertility, defects in eye development and optic nerve hypoplasia in mice","volume":"12","author":"Rodemer","year":"2003","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1399-0004.1989.tb02912.x","article-title":"Birth prevalence rates of skeletal dysplasias","volume":"35","author":"Stoll","year":"1989","journal-title":"Clin. Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0265","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/hmg\/ddp110","article-title":"Defects in myelination, paranode organization and Purkinje cell innervation in the ether lipid-deficient mouse cerebellum","volume":"18","author":"Teigler","year":"2009","journal-title":"Hum Mol Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0270","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/jimd.12264","article-title":"Oral batyl alcohol supplementation rescues decreased cardiac conduction in ether phospholipid-deficient mice","volume":"43","author":"Todt","year":"2020","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.brainres.2024.149132_b0275","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/BF02435984","article-title":"Human dihydroxyacetonephosphate acyltransferase deficiency: a new peroxisomal disorder","volume":"15","author":"Wanders","year":"1992","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.brainres.2024.149132_b0280","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/BF00711817","article-title":"Human alkyldihydroxyacetonephosphate synthase deficiency: a new peroxisomal disorder","volume":"17","author":"Wanders","year":"1994","journal-title":"J Inherit Metab Dis."},{"key":"10.1016\/j.brainres.2024.149132_b0285","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fgene.2014.00088","article-title":"Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models","volume":"5","author":"Webster","year":"2014","journal-title":"Front Genet."},{"key":"10.1016\/j.brainres.2024.149132_b0290","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/ajmg.a.20009","article-title":"Natural history of rhizomelic chondrodysplasia punctata","volume":"118A","author":"White","year":"2003","journal-title":"Am J Med Genet a."},{"key":"10.1016\/j.brainres.2024.149132_b0295","unstructured":"Wood, P.L., Khan, A.M., Mankidy, R., Smith, T., Goodenowe, D., 2011a. Plasmalogen Deficit: A New and Testable Hypothesis for the Etiology of Alzheimer's Disease. In Alzheimer's Disease Pathogenesis-Core Concepts, Shifting Paradigms and Therapeutic Targets. Vol., S. De La Monte, ed.^eds. InTech."},{"key":"10.1016\/j.brainres.2024.149132_b0300","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1503\/jpn.090059","article-title":"Circulating plasmalogen levels and Alzheimer Disease Assessment Scale-Cognitive scores in Alzheimer patients","volume":"35","author":"Wood","year":"2010","journal-title":"J. Psychiatry Neurosci."},{"key":"10.1016\/j.brainres.2024.149132_b0305","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/1476-511X-10-214","article-title":"Cellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens","volume":"10","author":"Wood","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.brainres.2024.149132_b0310","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/neu.2015.18","article-title":"Non-targeted lipidomics of CSF and frontal cortex grey and white matter in control, mild cognitive impairment, and Alzheimer's disease subjects","volume":"27","author":"Wood","year":"2015","journal-title":"Acta Neuropsychiatr."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932400386X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000689932400386X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T12:17:23Z","timestamp":1732450643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000689932400386X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":62,"alternative-id":["S000689932400386X"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149132","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel inducible animal model for studying chronic plasmalogen deficiency associated with Alzheimer\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2024.149132","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"149132"}}